Evidence map›Paper›PMID 41351171›Full record

ReviewMalaria journal2025

Host defense peptides in malaria infection: their contributions, significance and constraints.

Dia Aldeen Alfaki, Mohamed Mubarak Elbasheir

Abstract readReview
In one paragraph

Review in Malaria journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Dia Aldeen AlfakiDepartment of Haematology, Faculty of Medical Laboratory Sciences, Alzaeim Alazhari University, Khartoum, Sudan. dia-hassan@outlook.com.ORCID http://orcid.org/0000-0002-2314-2074
Mohamed Mubarak ElbasheirDepartment of Parasitology, Faculty of Medical Laboratory Sciences, Alzaeim Alazhari University, Khartoum, Sudan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Plasmodium-induced malaria infection remains a leading global health threat. Host defense peptides (HDPs), key components of innate immunity, target multiple stages of Plasmodium development through direct antimicrobial activity and immunomodulation. These peptides represent promising agents as antimalarial compounds due to their dual role in directly targeting Plasmodium parasites and modulating host immune responses. Several HDPs, including defensins, cathelicidins, NK-2 peptide, platelet factor 4, macrophage inflammatory protein-3α, and hepcidin play pivotal roles in protecting against malaria infection. However, the roles and specific targets of HDPs in malaria defense remain incompletely understood. This review outlines the key HDPs involved in malaria defense, as well as recent findings about their specific roles towards Plasmodium parasites and infected cells. Furthermore, advancements in understanding HDP interactions with Plasmodium at various infection stages, as well as their roles in modulating the host immune response are discussed. Also, the current limitations in uncovering the full implications of HDPs in malaria infection are highlighted.

Indexed as

Antimicrobial PeptidesImmunity, InnateMalariaPlasmodiumAnimalsHumansAntimicrobial PeptidesAntimicrobialHost defense peptidesImmunomodulationPlasmodium

Identifiers

PMID41351171
PMCPMC12797382

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.